Erika Carmel-Tech Ltd (TLV:ERKA)

Israel · Delayed Price · Currency is ILS · Price in ILA

50.60

+0.50 (1.00%)

Jul 17, 2026, 1:44 PM IDT

-22.45% (1Y)

Market Cap	21.08M -22.5%
Revenue (ttm)	37.34M -1.6%
Net Income	-5.85M
EPS	-0.14
Shares Out	41.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,100
Open	51.90
Previous Close	50.10
Day's Range	50.60 - 51.90
52-Week Range	37.50 - 77.50
Beta	1.03
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About Erika Carmel-Tech

Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It provides B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. The company treats achilles tendon inflammation, burns, carpal tunnel syndrome, finger joint pain, fibromyalgia, hip pain, post-dental treatment, lower ... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2007

Employees 45

Stock Exchange Tel Aviv Stock Exchange

Ticker Symbol ERKA

Full Company Profile

Financial Performance

In 2025, Erika Carmel-Tech's revenue was 37.34 million, a decrease of -1.64% compared to the previous year's 37.96 million. Losses were -5.85 million, -38.19% less than in 2024.

Financial Statements